CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents

Journal of Infection

Volumn 69, Issue 6, 2014, Pages 569-580

  Tang, Xiao Lei ^a   Zhou, Ya Xiong ^a   Wu, Si Min ^a,b   Pan, Qin ^a   Xia, Bing ^c   Zhang, Xiao Lian ^a  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Medical Treatment Center   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Antigen diagnostic reagents; Aptamers; CFP10 ESAT6 (CE); Enzyme linked oligonucleotide assay (ELONA); Tuberculosis

Indexed keywords

APTAMER; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; RECOMBINANT PROTEIN; SINGLE STRANDED DNA; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ADULT; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; ENZYME LINKED OLIGONUCLEOTIDE ASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; IMMUNOASSAY; IN VITRO STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BINDING; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; DIAGNOSTIC USE; DNA MICROARRAY; IMMUNOLOGY; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONLINEAR SYSTEM; NORMAL HUMAN; TUBERCULOSIS, PULMONARY;

ADULT; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; APTAMERS, NUCLEOTIDE; BACTERIAL PROTEINS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NONLINEAR DYNAMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUBERCULOSIS, PULMONARY;

EID: 84922778519     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.05.015     Document Type: Article

References (53)

1. Lienhardt C., Glaziou P., Uplekar M., Lonnroth K., Getahun H., Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 2012, 10:407-416.
2. Yew W.W., Borgdorff M.W., Enarson D.A. New tools for global tuberculosis control: are we any closer?. Int J Tuberc Lung Dis 2012, 16:855-856.
3. Glaziou P., Falzon D., Floyd K., Raviglione M. Global epidemiology of tuberculosis. Semin Respir Crit Care Med 2013, 34:3-16.
4. Solovic I., Jonsson J., Korzeniewska-Kosela M., Chiotan D.I., Pace-Asciak A., Slump E., et al. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. Euro Surveill 2013, 18(12). PII: 20432.
5. Rajasekharan C., Ajithkumar S., Anto V., Parvathy R. Extrapulmonary disseminated tuberculosis with tuberculous adrenalitis: a stitch in time saves nine. BMJ Case Rep 2013, PII: bcr2012008011. 10.1136/bcr-2012-008011.
6. Garcia-Rodriguez J.F., Alvarez-Diaz H., Lorenzo-Garcia M.V., Marino-Callejo A., Fernandez-Rial A., Sesma-Sanchez P. Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infecc Microbiol Clin 2011, 29:502-509.
7. Ducomble T., Tolksdorf K., Karagiannis I., Hauer B., Brodhun B., Haas W., et al. The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill 2013, 18:20436.
8. Firdessa R., Berg S., Hailu E., Schelling E., Gumi B., Erenso G., et al. Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerg Infect Dis 2013, 19:460-463.
9. McLachlan A.J., Arulventhan R. Extrapulmonary tuberculosis-three cases in the spine. Aust Fam Physician 2013, 42:204-206.
10. Tiwari B.R., Ghimire P., Malla S., Sharma B., Karki S. Intestinal parasitic infection among the HIV-infected patients in Nepal. J Infect Dev Ctries 2013, 7:550-555.
11. Gwee A., Pantazidou A., Ritz N., Tebruegge M., Connell T.G., Cain T., et al. To X-ray or not to X-ray? Screening asymptomatic children for pulmonary TB: a retrospective audit. Arch Dis Child 2013, 98:401-404.
12. Lopez T., Moreno M., Salvador F., Zacarias A., Carvalho R., Tomas E., et al. Tuberculosis diagnosed in a rural setting in Angola. Accuracy of follow-up sputum smears to predict outcome. Pathog Glob Health 2013, 107:5-10.
13. Kidenya B.R., Kabangila R., Peck R.N., Mshana S.E., Webster L.E., Koenig S.P., et al. Early and efficient detection of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. PLoS One 2013, 8:e57527.
14. Taubman D., Titler N., Edelstein H., Elias M., Saliba W. Providing detailed information about latent tuberculosis and compliance with the PPD test among healthcare workers in Israel: a randomized controlled study. J Epidemiol Glob Health 2013, 3:253-260.
15. Jam S., Sabzvari D., SeyedAlinaghi S., Fattahi F., Jabbari H., Mohraz M. Frequency of Mycobacterium tuberculosis infection among Iranian patients with HIV/AIDS by PPD test. Acta Med Iran 2010, 48:67-71.
16. Ajantha G.S., Shetty P.C., Kulkarni R.D., Biradar U. PCR as a diagnostic tool for extra-pulmonary tuberculosis. J Clin Diagn Res 2013, 7:1012-1015.
17. Moure R., Martin R., Alcaide F. Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence. J Clin Microbiol 2012, 50:513-515.
18. Mehta P.K., Raj A., Singh N., Khuller G.K. Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol 2012, 66:20-36.
19. Raja A., Ranganathan U.D., Bethunaickan R. Improved diagnosis of pulmonary tuberculosis by detection of antibodies against multiple Mycobacterium tuberculosis antigens. Diagn Microbiol Infect Dis 2008, 60:361-368.
20. Aagaard C., Govaerts M., Meikle V., Vallecillo A.J., Gutierrez-Pabello J.A., Suarez-Guemes F., et al. Optimizing antigen cocktails for detection of Mycobacterium bovis in herds with different prevalences of bovine tuberculosis: ESAT6-CFP10 mixture shows optimal sensitivity and specificity. J Clin Microbiol 2006, 44:4326-4335.
21. Berthet F.X., Rasmussen P.B., Rosenkrands I., Andersen P., Gicquel B.A. Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998, 144(Pt 11):3195-3203.
22. Renshaw P.S., Panagiotidou P., Whelan A., Gordon S.V., Hewinson R.G., Williamson R.A., et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 2002, 277:21598-21603.
23. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., Hewinson R.G. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 2001, 8:571-578.
24. Weldingh K., Andersen P. Replacing the tuberculin skin test with a specific blood test. Kekkaku 2005, 80:581-585.
25. Weldingh K., Andersen P. ESAT-6/CFP10 skin test predicts disease in M. tuberculosis-infected guinea pigs. PLoS One 2008, 3:e1978.
26. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
27. Stoltenburg R., Reinemann C., Strehlitz B. SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 2007, 24:381-403.
28. Ellington A.D., Szostak J.W. Invitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
29. Gu G., Wang T., Yang Y., Xu X., Wang J. An improved SELEX-Seq strategy for characterizing DNA-binding specificity of transcription factor: NF-kappaB as an example. PLoS One 2013, 8:e76109.
30. Hu K., Beck J., Nassal M. SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription. Nucleic Acids Res 2004, 32:4377-4389.
31. Bouvet P. Identification of nucleic acid high-affinity binding sequences of proteins by SELEX. Methods Mol Biol 2009, 543:139-150.
32. Chen F., Hu Y., Li D., Chen H., Zhang X.L. CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2. PLoS One 2009, 4:e8142.
33. Pan Q., Zhang X.L., Wu H.Y., He P.W., Wang F., Zhang M.S., et al. Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi. Antimicrob Agents Chemother 2005, 49:4052-4060.
34. Chen F., Zhou J., Luo F., Mohammed A.B., Zhang X.L. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun 2007, 357:743-748.
35. Chen F., Zhang X., Zhou J., Liu S., Liu J. Aptamer inhibits Mycobacterium tuberculosis (H37Rv) invasion of macrophage. Mol Biol Rep 2012, 39:2157-2162.
36. Motulsky H., Christopoulos A. Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting 2004, Oxford University Press, Oxford.
37. Guo S., Xue R., Li Y., Wang S.M., Ren L., Xu J.J. The CFP10/ESAT6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection. Med Hypotheses 2012, 78:389-392.
38. Krohn K.A., Link J.M. Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple. Nucl Med Biol 2003, 30:819-826.
39. Hermann T., Patel D.J. Adaptive recognition by nucleic acid aptamers. Science 2000, 287:820-825.
40. Rotherham L.S., Maserumule C., Dheda K., Theron J., Khati M. Selection and application of ssDNA aptamers to detect active TB from sputum samples. PLoS One 2012, 7:e46862.
41. Feng X., Xiu B., Chen K., Yang X., Zhang H., Yue J., et al. Enhanced serodiagnostic utility of novel Mycobacterium tuberculosis polyproteins. J Infect 2013, 66:366-375.
42. Connell T.G., Ritz N., Paxton G.A., Buttery J.P., Curtis N., Ranganathan S.C. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS One 2008, 3:e2624.
43. Connell T.G., Tebruegge M., Ritz N., Bryant P.A., Leslie D., Curtis N. Indeterminate interferon-gamma release assay results in children. Pediatr Infect Dis J 2010, 29:285-286.
44. Connell T.G., Tebruegge M., Ritz N., Bryant P., Curtis N. The potential danger of a solely interferon-gamma release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children. Thorax 2011, 66:263-264.
45. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 2009, 30:585-591.
46. Kulshrestha A., Gupta A., Verma N., Sharma S.K., Tyagi A.K., Chaudhary V.K. Expression and purification of recombinant antigens of Mycobacterium tuberculosis for application in serodiagnosis. Protein Expr Purif 2005, 44:75-85.
47. Lee Y.M., Kim S.M., Park S.J., Park K.H., Lee S.O., Choi S.H., et al. Indeterminate T-SPOT. Test results in patients with suspected extrapulmonary tuberculosis in routine clinical practice. Infect Chemother 2013, 45:44-50.
48. Huo F.F., Zhang L.F., Liu X.Q. Sensitivity of interferon-gamma release assay T-SPOT. TB in diagnosing extrapulmonary tuberculosis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009, 31:449-452.
49. Fu R., Wang C., Shi C., Lu M., Fang Z., Lu J., et al. An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein. Clin Vaccine Immunol 2009, 16:686-691.
50. Logan I., Bowlus C.L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010, 9:A372-A378.
51. Epstein D., Watermeyer G., Kirsch R. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther 2007, 25:1373-1388.
52. Jayanthi V., Robinson R.J., Malathi S., Rani B., Balambal R., Chari S., et al. Does Crohn's disease need differentiation from tuberculosis?. J Gastroenterol Hepatol 1996, 11:183-186.
53. Kirsch R., Pentecost M., Hall Pde M., Epstein D.P., Watermeyer G., Friederich P.W. Role of colonoscopic biopsy in distinguishing between Crohn's disease and intestinal tuberculosis. J Clin Pathol 2006, 59:840-844.